Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
We are committed to developing safe and effective therapeutic products that improve the lives of patients living with complex, life-threatening rare diseases with unmet medical needs.
We value team members who want to make a difference. For more information on career opportunities at Soleno, contact email@example.com
Developing novel therapeutics for the treatment of rare diseases.
Soleno Therapeutics Added to Russell 3000® Index
Soleno Therapeutics Announces Closing of $57.5 Million Public Offering of Common Stock, Including the Full Exercise of Underwriters’ Option to Purchase Additional Shares